The third study found no association between CRP and breast cancer risk for non-users (per 1 SD increase in concentration: HR 1.02, 95% CI: 0.92, 1.14), past users (HR 0.85, 95% CI: 0.67, 1.08), or current (HR 1.00, 95% CI: 0.90, 1.11) users of HRT, but these associations were not stratified by menopausal status [35]. Here, CRP is linked to breast carcinoma.